A Case of Leiomyosarcoma of the Nasal Cavity with Neurofibromatosis Type 1
-
- Onoe Yoshihiro
- Yamagata University School of Medicine
-
- Koike Shuji
- Yamagata University School of Medicine
-
- Nasu Takashi
- Yamagata University School of Medicine
-
- Noda Daisuke
- Yamagata University School of Medicine
-
- Ishida Akihiro
- Yamagata University School of Medicine
-
- Ishii Kenichi
- Yamagata University School of Medicine
-
- Aoyagi Masaru
- Yamagata University School of Medicine
Bibliographic Information
- Other Title
-
- 神経線維腫症I型(von Recklinghausen病)に合併した鼻腔平滑筋肉腫例
- 臨床 神経線維腫症1型(von Recklinghausen病)に合併した鼻腔平滑筋肉腫例
- リンショウ シンケイ センイ シュショウ 1ガタ von Recklinghausenビョウ ニ ガッペイ シタ ビクウ ヘイカツキン ニクシュレイ
Search this article
Abstract
We report a case of leiomyosarcoma of the nasal cavity with neurofibromatosis type 1 (NF1). Leiomyosacoma accounts for 5-7% of all soft-tissue sarcomas and occurs most often in the gastrointestinal tract and uterus. Leiomyosarcoma of the sinonasal tract is rare.<br> A 66-year-old man with NF1 and reporting left nasal obstruction and recurrent epistaxis was found in endoscopic observation to have a reddish tumor of the left nasal cavity. Computed tomography (CT) of the paranasal sinuses showed an oval tumor arising from the inferior turbinate and filling the left nasal cavity. T1-weighted magnetic resonance imaging (MRI) showed the homogenous enhanced tumor to have almost the same signal intensity as a subcutaneous neurofibroma of the scalp. The nasal tumor was surgically removed by Deker’s method. Immunohistochemical staining of the resected tumor showed tumor cells positive for α-smooth muscle actin and neuron-specific enolase, but negative for S-100 protein, CD34, and CD56. The tumor was diagnosed as a leiomyosarcoma. The patient was discharged without postsurgical treatment and is being followed up, showing no recurrence or metastasis as of this writing.<br> NF1 is an autosomal-dominant hereditary disorder that occurs in every 3,000 live births in Japan. The risk of malignancy among NF1 patients is higher than among the general population, i.e., the NF1 gene is a tumor suppressor gene of which mutation involves a fourfold increased risk for cancer. The NF1 gene product neurofibromin is thought to deliver much of its function by downregulating the oncogene ras. Leiomyosarcoma pathogenesis in our subject may thus be associated with the NF1 gene.<br> Our case is, to the best of our knowledge, the first clinical report of leiomyosarcoma in the head and neck region with NF1.<br>
Journal
-
- Practica Oto-Rhino-Laryngologica
-
Practica Oto-Rhino-Laryngologica 102 (11), 931-937, 2009
The Society of Practical Otolaryngology
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679240025984
-
- NII Article ID
- 10025527376
-
- NII Book ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL BIB ID
- 10482941
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed